Compare LXP & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXP | PBH |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | 1993 | 2005 |
| Metric | LXP | PBH |
|---|---|---|
| Price | $51.55 | $66.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $54.17 | ★ $85.40 |
| AVG Volume (30 Days) | ★ 466.9K | 399.7K |
| Earning Date | 02-12-2026 | 02-05-2026 |
| Dividend Yield | ★ 5.43% | N/A |
| EPS Growth | ★ 487.65 | N/A |
| EPS | 1.90 | ★ 3.79 |
| Revenue | $364,335,000.00 | ★ $1,103,606,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.97 | $2.24 |
| P/E Ratio | $27.17 | ★ $17.29 |
| Revenue Growth | ★ 6.98 | N/A |
| 52 Week Low | $34.25 | $57.25 |
| 52 Week High | $52.52 | $90.04 |
| Indicator | LXP | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 69.19 | 52.57 |
| Support Level | $49.52 | $63.69 |
| Resistance Level | $49.76 | $68.62 |
| Average True Range (ATR) | 0.99 | 2.10 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 100.00 | 39.98 |
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.